A Breath-THC Development Poster Did Not Establish a Universal Impairment Window

A development poster describing a marijuana breathalyzer did not establish a universal interval of impairment after cannabis use. Its preliminary breath measurements and proposed testing architecture need to be distinguished from a validated driving-performance decision rule.

What the poster described

Dunk and colleagues presented a portable-device development approach involving breath collection, a rapid detection system and laboratory confirmation. The poster reported a sharp breath-THC signal soon after smoking and a decline toward very low levels over roughly two to three hours.

These are claims from a development poster, not an independent clinical validation trial. The available presentation did not provide enough participant and performance detail to estimate a general error rate for identifying impaired drivers.

Detection timing is not functional timing

The poster associated its proposed detection window with peak impairment, but its preliminary driver-testing material did not establish that correspondence across users. Breath collection conditions, including the surrounding environment, were also part of the development problem.

A biomarker that falls quickly may help address recent exposure. It still requires a separately defined performance reference before its concentration or detection window can classify impairment. A window observed after smoking also should not be transferred automatically to oral cannabis.

Confirmation has a specific role

A split collection intended to allow laboratory confirmation can strengthen chemical identification if successfully implemented and validated. It does not, by itself, validate an impairment interpretation or establish when someone can safely drive.

The useful question is which part of the proposed system has supporting data: collection, chemical detection, confirmation or functional classification. This undated poster supports discussion of development goals and preliminary observations, without establishing the current capabilities of any marketed device.

Related: How the reference specimen changes a cannabis accuracy claim.

Research cited

Dunk K; Heanue J; Jain H; et al.; Development poster; undated. Development of a Portable Marijuana Breathalyzer.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

A Living-Subject Cannabis Blood-Fraction Ratio Did Not Validate Postmortem Conversion

A plasma-to-whole-blood relationship observed in living cannabis users did not validate the same conversion after death. Giroud and colleagues found substantially greater variability in postmortem samples and cautioned against applying an exposure-time model in that setting. The study compared different blood fractions The investigators examined cannabinoid measurements in eight living…

Spread the love

Read Article: A Living-Subject Cannabis Blood-Fraction Ratio Did Not Validate Postmortem Conversion

A Cannabis Muscle-Tone Opinion Needs a Defined Measurement Method

A statement that someone’s muscle tone indicates cannabis impairment needs a defined observation and measurement method. A published perspective questions whether a subjective limb assessment can carry the same meaning as a standardized clinical evaluation. The critique concerns what was measured The perspective contrasts descriptions such as normal, rigid or…

Spread the love

Read Article: A Cannabis Muscle-Tone Opinion Needs a Defined Measurement Method

A THC-Positive Driver Case Series Did Not Supply a Drug-Free Specificity Group

A study selected from THC-positive driver investigations cannot establish drug-free specificity without a suitable negative comparison group. A two-year case review provides useful observations within its selected cases, but it does not answer every diagnostic-accuracy question. Selection happened before the final analysis Declues and colleagues began with THC-positive cases from…

Spread the love

Read Article: A THC-Positive Driver Case Series Did Not Supply a Drug-Free Specificity Group

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us